Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans
about
In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandinSCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbitsAntifungal effects of the nonlinear pharmacokinetics of cilofungin, a 1,3-beta-glucan synthetase inhibitor, during continuous and intermittent intravenous infusions in treatment of experimental disseminated candidiasisAntifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemiaAntifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbits.Surface hydrophobicity changes of two Candida albicans serotype B mnn4delta mutants.Microbiology and potential virulence of Sporothrix cyanescens, a fungus rarely isolated from blood and skin.Plasminogen alleles influence susceptibility to invasive aspergillosis.Antifungal activity of the pradimicin derivative BMS 181184 in the treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.Efficacy, plasma pharmacokinetics, and safety of icofungipen, an inhibitor of Candida isoleucyl-tRNA synthetase, in treatment of experimental disseminated candidiasis in persistently neutropenic rabbits.Correlation between in vitro and in vivo antifungal activities in experimental fluconazole-resistant oropharyngeal and esophageal candidiasisAntifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.Effects of the hematoregulatory peptide SK&F 107647 alone and in combination with amphotericin B against disseminated candidiasis in persistently neutropenic rabbits.Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits.Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate.Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia.Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.Multidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.Development and validation of a quantitative real-time PCR assay using fluorescence resonance energy transfer technology for detection of Aspergillus fumigatus in experimental invasive pulmonary aspergillosis.Posaconazole pharmacodynamic target determination against wild-type and Cyp51 mutant isolates of Aspergillus fumigatus in an in vivo model of invasive pulmonary aspergillosisQuantitative urine cultures do not reliably detect renal candidiasis in rabbitsCerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.Detection of a molecular biomarker for zygomycetes by quantitative PCR assays of plasma, bronchoalveolar lavage, and lung tissue in a rabbit model of experimental pulmonary zygomycosisIsolation and characterization of cell surface mutants of Candida albicansInduction and expression of cell-mediated immune responses in inbred mice infected with Coccidioides immitis.Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.Use of a mouse model to evaluate clinical and environmental isolates of Sporothrix spp. from the largest U.S. epidemic of sporotrichosis.Impact of in vivo triazole and echinocandin combination therapy for invasive pulmonary aspergillosis: enhanced efficacy against Cyp51 mutant isolatesIsavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus.Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
P2860
Q28316952-DFD731F2-0019-47B9-86DC-07953F978E1CQ28331634-99527656-26E3-4DFB-A4B5-0FD5ECE84A51Q28333673-08ABECBE-76C8-470C-AC86-92B0EF85A5C6Q28349552-07FEE591-B364-47E5-A77C-695B38CF1560Q28369150-1194AFF6-14BD-48E6-A8F7-BF58DE73B15FQ30436513-4ADF7680-CA3D-439A-AE38-5E5B3E784E74Q30604771-42801AB9-D846-4FE9-94BC-F838EFAF90DBQ33345242-99DDFAE1-48AB-4930-8D0E-9FFB9A0D51D2Q33697110-844F8141-A819-4F8D-B36D-3D051EB9FD11Q33770019-52F25886-364C-458B-B3E3-C16D347BB371Q33967543-8203D88A-1690-4375-A3E8-51CBD165E7D5Q33977578-8AD137A8-40E8-4B02-A1BD-E52E714A4490Q33977593-524114D0-2ADE-4E1D-AA75-A13D57CBACB4Q33977852-2A2DE590-0B99-4F2B-9288-6988E1AE02FAQ33981387-0BC1957A-8356-4277-A3A4-2A638E614230Q33983618-F9CE02B7-DD0D-4EC0-BCB1-156581C26E65Q34104748-B591FA50-ECB0-4FF3-8F6D-05070AC13D2AQ34108880-74BA6E63-674A-4ED7-8CEC-47125F43B84FQ34510443-9A2C0015-2FB2-4863-B947-1715B4A85246Q34952419-A6886B38-72D1-4410-84CB-49994C8FAAB0Q36505539-8AB66F15-7EED-4D12-89E5-9A5205CD774FQ36548257-C925E36A-D533-4BB7-B2AD-149962BCA62BQ36949545-6DE6068A-1AEA-4B04-95F6-C57889E070FDQ36957985-57A0A97E-7A1E-42F1-A244-B4CF1A294A06Q36982215-C25910F3-C712-43CE-B09D-AA86C8F088C3Q36992148-6A1CB1FA-F403-40A1-B233-7517D58B24EFQ37119029-7B4E16A6-BEBA-4085-9500-08EFB221B197Q37119054-C2D9EA1B-DF4A-477C-B68A-21490CC34911Q37263430-86627D96-F116-49D5-8CE6-1FF41F4100DBQ37335649-FB0A646E-2E80-40F9-88D9-CCCA5D6B7AF6Q37383763-E3FB3CC3-1C3C-4820-825E-BAFDC5D82D40Q37568979-AC842B44-BD18-4BB4-A7DA-A0EC6ADDFBBB
P2860
Tissue homogenization with sterile reinforced polyethylene bags for quantitative culture of Candida albicans
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 1987
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tissue homogenization with ste ...... ve culture of Candida albicans
@en
Tissue homogenization with ste ...... e culture of Candida albicans.
@nl
type
label
Tissue homogenization with ste ...... ve culture of Candida albicans
@en
Tissue homogenization with ste ...... e culture of Candida albicans.
@nl
prefLabel
Tissue homogenization with ste ...... ve culture of Candida albicans
@en
Tissue homogenization with ste ...... e culture of Candida albicans.
@nl
P2093
P2860
P1476
Tissue homogenization with ste ...... ve culture of Candida albicans
@en
P2093
P2860
P304
P407
P577
1987-05-01T00:00:00Z